Ann: POH Decides to Put its BioElixia Cosmetic Brand Up For Sale, page-21

Given the pedigree of the product (the brain child of scientists now in prison) I reckon a bikie club should buy it. And sell the fat cream to struggling country football teams as a way of cleverly circumventing the laws around ADO094.

How many people are required to run POH for the purposes of conducting two P2 trials of oxyc/oxym through investigators in Australia and a CRO in the US?

About four. Everything else is just leakage. Because $19m "amazingly" has been injected into POH to complete these two trials – not waste more time and money on a failed business model.

The oxym trial (but not the Oxyc trial) will produce a big-time biotech binary outcome. It is fair to say that more people probably believe in the second coming than the number of people who think POH after a decade will even manage to get to the starting gate and submit an IND for the oxym trial.

But when (and if) POH do the sp should get a good bounce as some sort of miracle dividend. As some of that “amazing” $19m goes into the black and those investors exit to their great relief.

In addition given POH’s track record no-one sensible will be holding when the oxym binary outcome occurs. And so again the sp should rise in expectation of the trial results to allow money to exit at good profit from the cr at 8cents.

So every way I look at it the sp should rise. POH just have to do something. Which seems to be proving very difficult. No doubt because unlike acne and fat creams FDA stuff can’t be fudged.

Maybe take a bet on the second coming and use POH as a hedge.